Clinical Trials Logo
  1. Home
  2. Other
  3. NCT04012151

Arm and Finger Measurement for Blood Pressure Surveillance — ARMFIN  

Hypertension, Pregnancy-Induced Clinical Trial

Official title:
Arm and Finger Measurement for Blood Pressure Surveillance

Clinical Trial Summary

Accurate blood pressure (BP) measurement is critical in peripartum care. The cuff and bladder sizes affects the accuracy of BP measurement. Current international BP measurement recommendations are based on mid-arm circumference (MAC). However, evidence have shown the discrepancies between these sizes, leading to inaccuracy of BP measurement. This study will measure arm and finger size of 300 parturients in third trimester to determine whether the MAC, finger measurement or body mass index (BMI) is the best clinical predictor for non-standard cuff sizes for BP measurement.

Clinical Trial Description

Accurate blood pressure (BP) measurement plays an important role in peripartum care as it is essential in detecting hypertensive disorders in pregnancy and medical decision making during the pregnancy. The cuff and bladder size have been highlighted as an important factor affecting the accuracy of BP measurement. Current international BP measurement recommendations are based on mid-arm circumference (MAC) assuming the arm is cylindrical in shape. However, evidence have shown a mismatch between these sizes, leading to BP overestimation or underestimation in obese patients. This is because the shape of the arm is a truncated cone instead of a cylinder, and the cuff will expand irregularly during inflation thus yielding inaccurate BP measurements. This is especially evident in Asian pregnant patients whereby no available guideline can recommend a suitable cuff for parturients with different MAC. Nexfin is a finger cuff device that can be a suitable alternative BP measurement device for such patients. In this study 300 parturients will be recruited in third trimester and undergoing nonemergent caesarean section in KKH. Patients' arm and finger sizes will be measured, and their user experience on current practices on BP measurement. The arm measurements will help to identify the proportion of women that may require non-standard cuff sizes for BP measurement. A conicity index will be determined whether the MAC, finger measurement or BMI is the best clinical predictor. The finger measurements will also help to determine the proportion of women that may require non-standard cuff sizes on the Nexfin device for BP measurement. The knowledge gathered in this pilot study will be used to design future studies in which the accuracy of Nexfin will be compared with standard BP measurement, which in turn will improve BP detection, subsequent patient monitoring and satisfaction. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04012151
Study type Observational
Source KK Women's and Children's Hospital
Contact
Status Active, not recruiting
Phase
Start date July 10, 2019
Completion date December 31, 2024
View Details
See also
  Status Clinical Trial Phase
Completed NCT03613714 - Innovation in Postpartum Care for Women With Hypertensive Disorders of Pregnancy N/A
Completed NCT02338687 - Low Dose Calcium to Prevent Preeclampsia Phase 4
Completed NCT04752475 - Lasix for the Prevention of De Novo Postpartum Hypertension Phase 3
Completed NCT03334149 - Blood Pressure Monitoring in High Risk Pregnancy to Improve the Detection and Monitoring of Hypertension N/A
Recruiting NCT03298802 - Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide Phase 3
Completed NCT03076619 - A Clinical Study of Fundus Findings in Toxaemia of Pregnancy N/A
Recruiting NCT05473767 - Expanding the Family Check-Up in Early Childhood to Promote Cardiovascular Health of Mothers and Young Children N/A
Completed NCT03356106 - Screening and Treatment of Obstructive Sleep Apnea in High-risk Pregnancy N/A
Recruiting NCT05849103 - Comprehensive Postpartum Management for Women With Hypertensive Disorders of Pregnancy N/A
Recruiting NCT03200743 - Catestatin and Hypertension in Pregnancy N/A
Terminated NCT04343235 - Postpartum Management of Gestational Hypertensive Disorders Using Furosemide Phase 4
Completed NCT01508208 - Comparison of Urine Protein/Creatinine Ratio With 24-hour Urine Protein Excretion in Woman With Hypertensive Disorders N/A
Active, not recruiting NCT04580927 - Breastfeeding and Postpartum Cardiovascular Health N/A
Recruiting NCT03858595 - Optimizing Gestational Weight Gain, Birth Weight and Other Perinatal Outcomes Among Pregnant Women at Risk of Hypertension in Pregnancy N/A
Recruiting NCT05655936 - Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial N/A
Completed NCT02523781 - Evaluation of an Information Pamphlet for Postpartum Women That Had a Hypertensive Pregnancy N/A
Completed NCT01736826 - Free DNA and Nucleosome Concentrations in Pathological Pregnancies
Completed NCT03556761 - Furosemide for Accelerated Recovery of Blood Pressure Postpartum Phase 2
Completed NCT00949260 - Hemodynamic Assessment of Healthy and Hypertensive Pregnant Women by Non-Invasive Bio-Reactance N/A
Completed NCT04615624 - Furosemide vs. Placebo for Severe Antepartum Hypertension Phase 3